The Potential Role of STAT's in Anti-Leukemic Therapy with Different Drugs

被引：0
|
作者：
Kiper, Hatice Demet [1 ]
Kaymaz, Burcin Tezcanli [1 ]
Purclutepe, Ozlem [1 ]
Dalgic, Ceyda Tunakan [1 ]
Selvi, Nur [1 ]
Dalmizrak, Aysegul [2 ]
Avci, Cigir Biray [2 ]
Kosova, Buket [2 ]
Sahin, Fahri [3 ]
Aktan, Cagdas [1 ]
Saydam, Guray [3 ]
机构：
[1] Ege Univ, Sch Med, Bomova Izmir, Turkey
[2] Ege Univ, Sch Med Med Biol, Bomova Izmir, Turkey
[3] Ege Univ, Sch Med Hematol, Bomova Izmir, Turkey
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.5120.5120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5120
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2
    Kiffin, Roberta
    Wiktorin, Hanna Grauers
    Nilsson, Malin S.
    Aurelius, Johan
    Aydin, Ebru
    Lenox, Brianna
    Nilsson, Jonas A.
    Stahlberg, Anders
    Thoren, Fredrik B.
    Hellstrand, Kristoffer
    Martner, Anna
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [22] Expression of midkine(MDK) and sensitivity to anti-leukemic drugs in pediatric acute lymphoblastic leukemia (ALL)
    Zeng, Weihua
    Chen, I-Ming
    Tibbitts, Justin
    Kang, Huining
    Ar, Kerem
    BLOOD, 2007, 110 (11) : 429A - 429A
  • [23] Activation of JNK/SAPK in acute myelogenous leukemia blast cells by anti-leukemic drugs.
    Bonati, A
    Lunghi, P
    Pinelli, S
    Sassi, M
    Valmadre, G
    Ridolo, E
    Tassoni, I
    Albertini, R
    Dall'Aglio, P
    Carlo-Stella, C
    Tabilio, A
    Pelicci, PG
    BLOOD, 1999, 94 (10) : 217B - 217B
  • [24] Identification of substituted 5-membered heterocyclic compounds as potential anti-leukemic agents
    Ling, Taotao
    Maier, Julie
    Das, Sourav
    Budhraja, Amit
    Bassett, Rachel
    Potts, Malia B.
    Shelat, Anang
    Rankovic, Zoran
    Opferman, Joseph T.
    Rivas, Fatima
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 164 : 391 - 398
  • [25] Withanolide-Type Steroids from Withania aristata as Potential Anti-Leukemic Agents
    Moujir, Laila M.
    Llanos, Gabriel G.
    Araujo, Liliana
    Amesty, Angel
    Bazzocchi, Isabel L.
    Jimenez, Ignacio A.
    MOLECULES, 2020, 25 (23):
  • [26] Development and evaluation of novel artemisinin-isatin hybrids with potential anti-leukemic cytotoxicity
    Wang, Peng
    Zhang, Zhe
    Cao, Wei
    Zhang, Xuan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Inhibition of trans-plasma membrane electron transport: A potential anti-leukemic strategy
    Prata, Cecilia
    Grasso, Carole
    Loizzo, Stefano
    Sega, Francesco Vieceli Dalla
    Caliceti, Cristiana
    Zambonin, Laura
    Fiorentini, Diana
    Hakim, Gabriele
    Berridge, Michael V.
    Landi, Laura
    LEUKEMIA RESEARCH, 2010, 34 (12) : 1630 - 1635
  • [28] Modeling anti-leukemic therapy by patient derived AML xenografts with distinct phenotypes/geneotypes
    Liu, Jinping
    An, Xiaoyu
    Wang, Na
    Wang, Di
    Huang, Liang
    Wu, Ran
    Cai, Jie
    Wery, Jean-Pierre
    Li, Henry
    CANCER RESEARCH, 2014, 74 (19)
  • [29] HLA-DRW ANTIGEN(S) ON PERIPHERAL-BLOOD (PB) CELLS AFTER CESSATION OF ANTI-LEUKEMIC THERAPY
    CASPER, J
    DUQUESNOY, R
    BORELLA, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 274 - 274
  • [30] Maintaining the Cellular Anti-Viral and Anti-Leukemic Activities in GvHD Patients Undergoing Extracorporeal Photophoresis Therapy
    Gossmann, Ruben A.
    Wang, Lei
    Ni, Ming
    Yang, Mingya
    Luft, Thomas
    Hegenbart, Ute
    Schonland, Stefan O.
    Wuchter, Patrick
    Eckstein, Volker
    Kruger, William Hermann
    Yerushalmi, Ronit
    Beider, Katia
    Nagler, Arnon
    Muller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Schmitt, Anita
    BLOOD, 2019, 134
12345